Many cancer drugs remain unproven 5 years after accelerated approval, a study finds

In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.

Related Keywords

United States ,San Diego ,California ,Houston ,Texas ,Norway ,Norwegian ,American ,Cherie Duvall Jones ,Ezekiel Emanuel ,Edward Cliff ,Jennifer Litton ,Journal Of The American Medical Association ,Md Anderson Cancer Center ,Harvard Medical School We ,University Of Pennsylvania ,Drug Administration ,American Association For Cancer Research ,American Medical Association ,American Association ,Cancer Research ,Harvard Medical School ,Cancer Center ,